Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Derivative Warrants Liability - Schedule of Outstanding Warrants and Terms (Details)

Derivative Warrants Liability - Schedule of Outstanding Warrants and Terms (Details) - $ / shares
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Outstanding 2,477,500 4,730,906
Exercisable 2,477,500  
Series (2015) [Member]    
Outstanding 1,502,500 1,502,500
Exercise Price $ 0.5  
Exercisable 1,502,500  
Exercisable Through April 2021  
Series (2016) [Member]    
Outstanding 375,000 2,628,406
Exercise Price $ 0.5  
Exercisable 375,000  
Exercisable Through March 2022  
Series (2018) [Member]    
Outstanding 600,000 600,000
Exercise Price $ 0.125  
Exercisable 600,000  
Exercisable Through November 2021  
First Warrant [Member]    
Outstanding [1]
Exercise Price [1]  
Exercisable Through [2] 0 0
[1] The number of First Warrant instruments has not been determined as the First Warrant provides the Lenders with 25% warrant coverage, with the warrant exercise price to be equal to the offering price in the Company's proposed public offering, or, in the event the Loan Amount are converted into ordinary shares, the warrant exercise price will be equal to the applicable closing bid price of the Company's shares at the time of the conversion of the Loan Amount. However, based on the share price of the Company as of December 31, 2019, the number of the First Warrant would have been 20,896,789 shares.
[2] The exercise period is three years from the date of the determination of the exercise price.